{"id":37593,"date":"2026-02-09T08:54:21","date_gmt":"2026-02-09T07:54:21","guid":{"rendered":"https:\/\/ggba.swiss\/hemostod-secures-chf-2-million-to-advance-donor-free-platelet-development\/"},"modified":"2026-02-09T08:56:12","modified_gmt":"2026-02-09T07:56:12","slug":"hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/","title":{"rendered":"HemostOD l\u00e8ve CHF 2 millions pour faire avancer le d\u00e9veloppement de plaquettes sans donneur"},"content":{"rendered":"\n<p>La biotech lausannoise <a href=\"https:\/\/www.hemostod.com\/\">HemostOD<\/a> a obtenu une bourse de CHF 2 millions de la part d\u2019<a href=\"https:\/\/www.innosuisse.admin.ch\/fr\">Innosuisse<\/a>, l\u2019agence suisse pour l\u2019innovation, afin de soutenir le d\u00e9veloppement pr\u00e9clinique de ses plaquettes sanguines humaines sans donneur et pr\u00eates \u00e0 l\u2019emploi. Ce financement non dilutif contribuera \u00e0 franchir des \u00e9tapes cl\u00e9s vers la translation clinique.<\/p>\n\n\n\n<p>HemostOD est pionni\u00e8re dans la fabrication ex vivo de plaquettes sanguines humaines universelles \u00e0 partir de cellules souches h\u00e9matopo\u00ef\u00e9tiques immortalis\u00e9es et d\u2019une plateforme propri\u00e9taire de bior\u00e9acteurs. La technologie de l\u2019entreprise vise \u00e0 r\u00e9pondre aux p\u00e9nuries r\u00e9currentes de plaquettes \u00e0 l\u2019\u00e9chelle mondiale, qui touchent chaque ann\u00e9e des millions de patients, notamment en oncologie, en traumatologie et en chirurgie. En supprimant la d\u00e9pendance aux dons de sang, la plateforme ambitionne d\u2019am\u00e9liorer la fiabilit\u00e9 de l\u2019approvisionnement, la s\u00e9curit\u00e9 et l\u2019efficacit\u00e9 des co\u00fbts.<\/p>\n\n\n\n<p>Selon l\u2019entreprise, la bourse Innosuisse renforce sa position financi\u00e8re alors qu\u2019elle se pr\u00e9pare \u00e0 des \u00e9tapes d\u00e9terminantes, notamment le lancement d\u2019une ligne pilote de production pour d\u00e9montrer la scalabilit\u00e9 commerciale de la technologie et la tenue pr\u00e9vue d\u2019une r\u00e9union pr\u00e9-IND (Investigational New Drug) avec la Food and Drug Administration (FDA) am\u00e9ricaine afin d\u2019aligner les exigences r\u00e9glementaires.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Soutenir l\u2019innovation par des financements publics comp\u00e9titifs<\/h4>\n\n\n\n<p>Les bourses Innosuisse destin\u00e9es aux start-ups sont tr\u00e8s s\u00e9lectives, avec environ dix pour cent des candidatures accept\u00e9es. Le programme soutient des projets scientifiques pr\u00e9sentant un fort potentiel d\u2019innovation avant leur mise sur le march\u00e9, renfor\u00e7ant ainsi la position de la Suisse comme p\u00f4le d\u2019innovation biom\u00e9dicale.<\/p>\n\n\n\n<p>Gr\u00e2ce \u00e0 ce nouveau financement, HemostOD poursuit sa transition du stade de la preuve de concept vers la maturit\u00e9 industrielle, ouvrant la voie \u00e0 un nouveau paradigme potentiel en m\u00e9decine transfusionnelle fond\u00e9 sur un approvisionnement universel et sans donneur en plaquettes sanguines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>HemostOD a obtenu une bourse Innosuisse de CHF 2 millions pour soutenir le d\u00e9veloppement pr\u00e9clinique de ses plaquettes sanguines humaines sans donneur, pr\u00eates \u00e0 l\u2019emploi, destin\u00e9es \u00e0 la transfusion.<\/p>\n","protected":false},"author":6,"featured_media":37590,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1148,1188,1141,1142],"class_list":["post-37593","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-financing-fr-2","tag-healthcare-fr-2","tag-personalized-medicine-fr-2","tag-rd-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HemostOD l\u00e8ve CHF 2 millions | GGBa<\/title>\n<meta name=\"description\" content=\"HemostOD a lev\u00e9 CHF 2 millions pour soutenir le d\u00e9veloppement pr\u00e9clinique de ses plaquettes sanguines humaines sans donneur.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HemostOD l\u00e8ve CHF 2 millions | GGBa\" \/>\n<meta property=\"og:description\" content=\"HemostOD a lev\u00e9 CHF 2 millions pour soutenir le d\u00e9veloppement pr\u00e9clinique de ses plaquettes sanguines humaines sans donneur.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-09T07:54:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-09T07:56:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"HemostOD l\u00e8ve CHF 2 millions pour faire avancer le d\u00e9veloppement de plaquettes sans donneur\",\"datePublished\":\"2026-02-09T07:54:21+00:00\",\"dateModified\":\"2026-02-09T07:56:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/\"},\"wordCount\":342,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg\",\"keywords\":[\"Biotech\",\"Financing\",\"Healthcare\",\"Personalized Medicine\",\"R&amp;D\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/\",\"name\":\"HemostOD l\u00e8ve CHF 2 millions | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg\",\"datePublished\":\"2026-02-09T07:54:21+00:00\",\"dateModified\":\"2026-02-09T07:56:12+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"HemostOD a lev\u00e9 CHF 2 millions pour soutenir le d\u00e9veloppement pr\u00e9clinique de ses plaquettes sanguines humaines sans donneur.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"HemostOD d\u00e9veloppe une plateforme bas\u00e9e sur des bior\u00e9acteurs pour fabriquer \u00e0 l\u2019\u00e9chelle industrielle des plaquettes sanguines humaines universelles et sans donneur. | \u00a9 HemostOD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HemostOD l\u00e8ve CHF 2 millions pour faire avancer le d\u00e9veloppement de plaquettes sans donneur\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HemostOD l\u00e8ve CHF 2 millions | GGBa","description":"HemostOD a lev\u00e9 CHF 2 millions pour soutenir le d\u00e9veloppement pr\u00e9clinique de ses plaquettes sanguines humaines sans donneur.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/","og_locale":"fr_FR","og_type":"article","og_title":"HemostOD l\u00e8ve CHF 2 millions | GGBa","og_description":"HemostOD a lev\u00e9 CHF 2 millions pour soutenir le d\u00e9veloppement pr\u00e9clinique de ses plaquettes sanguines humaines sans donneur.","og_url":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-02-09T07:54:21+00:00","article_modified_time":"2026-02-09T07:56:12+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"HemostOD l\u00e8ve CHF 2 millions pour faire avancer le d\u00e9veloppement de plaquettes sans donneur","datePublished":"2026-02-09T07:54:21+00:00","dateModified":"2026-02-09T07:56:12+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/"},"wordCount":342,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg","keywords":["Biotech","Financing","Healthcare","Personalized Medicine","R&amp;D"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/","url":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/","name":"HemostOD l\u00e8ve CHF 2 millions | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg","datePublished":"2026-02-09T07:54:21+00:00","dateModified":"2026-02-09T07:56:12+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"HemostOD a lev\u00e9 CHF 2 millions pour soutenir le d\u00e9veloppement pr\u00e9clinique de ses plaquettes sanguines humaines sans donneur.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/02\/HemostOD-Product-1180x811-1.jpeg","width":1180,"height":811,"caption":"HemostOD d\u00e9veloppe une plateforme bas\u00e9e sur des bior\u00e9acteurs pour fabriquer \u00e0 l\u2019\u00e9chelle industrielle des plaquettes sanguines humaines universelles et sans donneur. | \u00a9 HemostOD"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/hemostod-leve-chf-2-millions-pour-faire-avancer-le-developpement-de-plaquettes-sans-donneur\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"HemostOD l\u00e8ve CHF 2 millions pour faire avancer le d\u00e9veloppement de plaquettes sans donneur"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/37593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=37593"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/37593\/revisions"}],"predecessor-version":[{"id":37595,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/37593\/revisions\/37595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/37590"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=37593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=37593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=37593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}